- IN₹181.36bn
- IN₹202.94bn
- IN₹31.29bn
Brief: Eris Lifesciences - Proposes To Acquire Portfolio Of Dermatology Brands From Glenmark
Brief: India's Eris Lifesciences Dec-Quarter Consol Net Profit 1.02 Billion Rupees
Brief: India's Eris Lifesciences Sept-Quarter Consol Net Profit Rises
Media: India's Eris Lifesciences scouting for acquisitions to diversify business - ET
Brief: Eris Lifesciences June-Quarter Consol Net Profit Slips
Brief: Eris Lifesciences Sees Consol Revenue Growth Of 30% In FY23
Brief: India's Eris Lifesciences March-Qtr Consol Net Profit Rises
Brief: Eris Lifesciences Dec-Quarter Consol Net Profit Rises
India's Eris Lifesciences jumps 10% on insulin business foray
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.18 Bln Rupees
Brief: Eris Lifesciences June-Quarter Consol Net Profit Rises
Brief: India's Eris Lifesciences March-Quarter Consol Net Profit Rises
Brief: Eris Lifesciences Says Re-Appointed Amit Bakshi As Managing Director For 5 Years
Brief: India's Eris Lifesciences Dec-Quarter Consol Net Profit Rises
Brief: India's Eris Lifesciences June-Quarter Consol Net Profit Rises
Brief: India's Eris Lifesciences March Quarter Consol Net Profit Rises
Brief: Eris Lifesciences March-Quarter Consol Profit Rises
Brief: Eris Lifesciences Approves Buyback Of Shares Worth Up To 1 Bln Rupees
Brief: Eris Lifesciences To Consider Proposal Of Buyback Of Fully Paid-Up Equity Shares